Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach

A new virus termed SARS-COV-2 (causing COVID-19 disease) can exhibit a progressive, fatal impact on individuals. The World Health Organization (WHO) has declared the spread of the virus to be a global pandemic. Currently, there are over 1 million cases and over 100,000 confirmed deaths due to the vi...

Full description

Bibliographic Details
Main Authors: Amit Joshi, Bhuwan Chandra Joshi, M. Amin-ul Mannan, Vikas Kaushik
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914820301581
_version_ 1818516994256797696
author Amit Joshi
Bhuwan Chandra Joshi
M. Amin-ul Mannan
Vikas Kaushik
author_facet Amit Joshi
Bhuwan Chandra Joshi
M. Amin-ul Mannan
Vikas Kaushik
author_sort Amit Joshi
collection DOAJ
description A new virus termed SARS-COV-2 (causing COVID-19 disease) can exhibit a progressive, fatal impact on individuals. The World Health Organization (WHO) has declared the spread of the virus to be a global pandemic. Currently, there are over 1 million cases and over 100,000 confirmed deaths due to the virus. Hence, prophylactic and therapeutic strategies are promptly needed. In this study we report an epitope, ITLCFTLKR, which is biochemically fit to HLA allelic proteins. We propose that this could be used as a potential vaccine candidate against SARS-COV-2. A selected putative epitope and HLA-allelic complexes show not only better binding scores, but also RMSD values in the range of 0–1 Å. This epitope was found to have a 99.8% structural favorability as per Ramachandran-plot analysis. Similarly, a suitable range of IC50 values and population coverage was obtained to represent greater validation of T-cell epitope analysis. Stability analysis using MDWeb and half-life analysis using the ProtParam tool has confirmed that this epitope is well-selected. This new methodology of epitope-based vaccine prediction is fundamental and fast in application, ad can be economically beneficial and viable.
first_indexed 2024-12-11T00:50:00Z
format Article
id doaj.art-5923fc8af3f64f50aca13be0771087fb
institution Directory Open Access Journal
issn 2352-9148
language English
last_indexed 2024-12-11T00:50:00Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Informatics in Medicine Unlocked
spelling doaj.art-5923fc8af3f64f50aca13be0771087fb2022-12-22T01:26:39ZengElsevierInformatics in Medicine Unlocked2352-91482020-01-0119100338Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approachAmit Joshi0Bhuwan Chandra Joshi1M. Amin-ul Mannan2Vikas Kaushik3Domain of Bioinformatics, School of Bio-Engineering and Bio-Sciences, Lovely Professional University, Punjab, IndiaDepartment of Biological Sciences and Biotechnology, Surajmal Agarwal Private Girls PG Degree College Kiccha, Kumaun University, Nainital, Uttarakhand, IndiaDomain of Bioinformatics, School of Bio-Engineering and Bio-Sciences, Lovely Professional University, Punjab, IndiaDomain of Bioinformatics, School of Bio-Engineering and Bio-Sciences, Lovely Professional University, Punjab, India; Corresponding author.A new virus termed SARS-COV-2 (causing COVID-19 disease) can exhibit a progressive, fatal impact on individuals. The World Health Organization (WHO) has declared the spread of the virus to be a global pandemic. Currently, there are over 1 million cases and over 100,000 confirmed deaths due to the virus. Hence, prophylactic and therapeutic strategies are promptly needed. In this study we report an epitope, ITLCFTLKR, which is biochemically fit to HLA allelic proteins. We propose that this could be used as a potential vaccine candidate against SARS-COV-2. A selected putative epitope and HLA-allelic complexes show not only better binding scores, but also RMSD values in the range of 0–1 Å. This epitope was found to have a 99.8% structural favorability as per Ramachandran-plot analysis. Similarly, a suitable range of IC50 values and population coverage was obtained to represent greater validation of T-cell epitope analysis. Stability analysis using MDWeb and half-life analysis using the ProtParam tool has confirmed that this epitope is well-selected. This new methodology of epitope-based vaccine prediction is fundamental and fast in application, ad can be economically beneficial and viable.http://www.sciencedirect.com/science/article/pii/S2352914820301581EpitopeImmuno-informaticsVaccineHLA-AllelesSimulationSARS-COV-2
spellingShingle Amit Joshi
Bhuwan Chandra Joshi
M. Amin-ul Mannan
Vikas Kaushik
Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
Informatics in Medicine Unlocked
Epitope
Immuno-informatics
Vaccine
HLA-Alleles
Simulation
SARS-COV-2
title Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
title_full Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
title_fullStr Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
title_full_unstemmed Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
title_short Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
title_sort epitope based vaccine prediction for sars cov 2 by deploying immuno informatics approach
topic Epitope
Immuno-informatics
Vaccine
HLA-Alleles
Simulation
SARS-COV-2
url http://www.sciencedirect.com/science/article/pii/S2352914820301581
work_keys_str_mv AT amitjoshi epitopebasedvaccinepredictionforsarscov2bydeployingimmunoinformaticsapproach
AT bhuwanchandrajoshi epitopebasedvaccinepredictionforsarscov2bydeployingimmunoinformaticsapproach
AT maminulmannan epitopebasedvaccinepredictionforsarscov2bydeployingimmunoinformaticsapproach
AT vikaskaushik epitopebasedvaccinepredictionforsarscov2bydeployingimmunoinformaticsapproach